| Interplay between MicroRNAs and oxidative stress in neurodegenerative diseases J Konovalova, D Gerasymchuk, I Parkkinen, P Chmielarz, A Domanskyi International journal of molecular sciences 20 (23), 6055, 2019 | 162 | 2019 |
| Implementation of deep neural networks to count dopamine neurons in substantia nigra AM Penttinen, I Parkkinen, S Blom, J Kopra, JO Andressoo, K Pitkänen, ... European Journal of Neuroscience 48 (6), 2354-2361, 2018 | 54 | 2018 |
| Back and to the future: from neurotoxin‐induced to human Parkinson's disease models M Airavaara, I Parkkinen, J Konovalova, K Albert, P Chmielarz, ... Current Protocols in Neuroscience 91 (1), e88, 2020 | 50 | 2020 |
| Pre-α-pro-GDNF and pre-β-pro-GDNF isoforms are neuroprotective in the 6-hydroxydopamine rat model of Parkinson's disease AM Penttinen, I Parkkinen, MH Voutilainen, M Koskela, S Bäck, A Their, ... Frontiers in neurology 9, 371449, 2018 | 32 | 2018 |
| Morphological heterogeneity of the endoplasmic reticulum within neurons and its implications in neurodegeneration S Sree, I Parkkinen, A Their, M Airavaara, E Jokitalo Cells 10 (5), 970, 2021 | 12 | 2021 |
| Neuronal activation stimulates cytomegalovirus promoter-driven transgene expression S Bäck, A Dossat, I Parkkinen, P Koivula, M Airavaara, CT Richie, ... Molecular Therapy-Methods & Clinical Development 14, 180-188, 2019 | 11 | 2019 |
| Nanoscale geometry determines mechanical biocompatibility of vertically aligned nanofibers S Rantataro, I Parkkinen, I Pande, A Domanskyi, M Airavaara, E Peltola, ... Acta Biomaterialia 146, 235-247, 2022 | 8 | 2022 |
| Roles of microRNAs in Parkinson’s and other neurodegenerative diseases Q Lai, N Murgia, I Parkkinen, A Domanskyi, IA Vinnikov AGO-Driven Non-Coding RNAs, 209-232, 2019 | 6 | 2019 |
| Pharmacological regulation of endoplasmic reticulum structure and calcium dynamics: importance for neurodegenerative diseases I Parkkinen, A Their, MY Asghar, S Sree, E Jokitalo, M Airavaara Pharmacological Reviews 75 (5), 959-978, 2023 | 5 | 2023 |
| Real-time selective detection of dopamine and serotonin at nanomolar concentration from complex in vitro systems S Rantataro, I Parkkinen, M Airavaara, T Laurila Biosensors and Bioelectronics 241, 115579, 2023 | 4 | 2023 |
| Development and optimisation of tools for preclinical studies on Parkinson's disease I Parkkinen Helsingin yliopisto, 2022 | 2 | 2022 |
| Palmitate and thapsigargin have contrasting effects on ER membrane lipid composition and ER proteostasis in neuronal cells MH Jäntti, SN Jackson, J Kuhn, I Parkkinen, S Sree, JJ Hinkle, E Jokitalo, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2022 | 1 | 2022 |
| Developing a cell-based fluorescent assay for screening Dicer-activating compounds I Parkkinen Helsingfors universitet, 2018 | | 2018 |
